ACS DOBFAR FDA Approval ANDA 062640

ANDA 062640

ACS DOBFAR

FDA Drug Application

Application #062640

Application Sponsors

ANDA 062640ACS DOBFAR

Marketing Status

Discontinued001
Prescription002
Prescription003
Prescription004

Application Products

001INJECTABLE;INJECTION500MG/VIAL0CEFTAZIDIMECEFTAZIDIME
002INJECTABLE;INJECTION1GM/VIAL0CEFTAZIDIMECEFTAZIDIME
003INJECTABLE;INJECTION2GM/VIAL0CEFTAZIDIMECEFTAZIDIME
004INJECTABLE;INJECTION6GM/VIAL0CEFTAZIDIMECEFTAZIDIME

FDA Submissions

ORIG1AP1985-11-20
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1988-08-04
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1988-08-26
LABELING; LabelingSUPPL10AP1992-02-14
LABELING; LabelingSUPPL13AP1992-02-14
LABELING; LabelingSUPPL14AP1992-02-14
LABELING; LabelingSUPPL15AP1992-02-03
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1993-10-18
LABELING; LabelingSUPPL19AP1996-02-26
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1996-08-15
LABELING; LabelingSUPPL21AP1996-07-15
LABELING; LabelingSUPPL24AP2006-09-08
LABELING; LabelingSUPPL30AP2009-04-07
LABELING; LabelingSUPPL33AP2012-03-16
LABELING; LabelingSUPPL34AP2013-02-11
LABELING; LabelingSUPPL40AP2020-02-13STANDARD
LABELING; LabelingSUPPL42AP2020-02-13STANDARD
LABELING; LabelingSUPPL44AP2021-07-16STANDARD
LABELING; LabelingSUPPL45AP2021-07-16STANDARD

Submissions Property Types

SUPPL8Null0
SUPPL9Null0
SUPPL18Null0
SUPPL20Null0
SUPPL33Null15
SUPPL34Null15
SUPPL40Null15
SUPPL42Null15
SUPPL44Null15
SUPPL45Null15

TE Codes

002PrescriptionAP
003PrescriptionAP
004PrescriptionAP

CDER Filings

ACS DOBFAR
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62640
            [companyName] => ACS DOBFAR
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"500MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"1GM\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"2GM\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CEFTAZIDIME","activeIngredients":"CEFTAZIDIME","strength":"6GM\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"500MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"1GM\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"2GM\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"CEFTAZIDIME","submission":"CEFTAZIDIME","actionType":"6GM\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.